Beximco Pharma completes Sanofi acquisition | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
July 12, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, JULY 12, 2025
Beximco Pharma completes Sanofi acquisition

Corporates

TBS Report
01 October, 2021, 08:25 pm
Last modified: 01 October, 2021, 09:56 pm

Related News

  • Beximco Pharma contributes to Labour Welfare Foundation
  • Beximco Pharma signs MoU with North South University
  • Beximco Pharma's share price plummets 47% since July
  • Beximco Pharma unaware of reasons behind share price drop
  • How Salman F Rahman makes billions with free bank money

Beximco Pharma completes Sanofi acquisition

Sanofi Bangladesh produces approximately 100 branded generic products, mainly for the local market

TBS Report
01 October, 2021, 08:25 pm
Last modified: 01 October, 2021, 09:56 pm
Beximco Pharma MD Nazmul Hassan, BCIC Chairman Shah Md Imdadul Haque among others at Beximco’s Sanofi acquisition ceremony on Thursday. Photo: Courtesy
Beximco Pharma MD Nazmul Hassan, BCIC Chairman Shah Md Imdadul Haque among others at Beximco’s Sanofi acquisition ceremony on Thursday. Photo: Courtesy

 

Beximco Pharmaceuticals Limited, a leading manufacturer and exporter of medicine in the country, has acquired a 54.6% stake in Sanofi Bangladesh Limited. 

A brief ceremony on the occasion took place on Thursday at a hotel in Dhaka, says a press release.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The event was attended by Beximco Pharma Managing Director Nazmul Hassan, BCIC Chairman Shah Md Imdadul Haque, Secretary to Industries Ministry, SM Alam, and other senior officials from both Sanofi and Beximco.

At the event, Nazmul Hassan said, "The completion of this deal is a major milestone for us. We have a clear strategy to continue our diversification and expansion, strengthening our position as a market-leading pharma company in Bangladesh. The acquisition of a majority stake in Sanofi Bangladesh is precisely in line with this strategy."

"We look forward to welcoming over 800 skilled and diligent Sanofi Bangladesh employees into our existing workforce. As a larger group, we are excited to continue our growth trajectory, delivering affordable treatments and breakthrough therapies to our growing domestic market," he added.

There is a new 5-member board of directors, with Nazmul Hassan, Rabbur Reza and Ali Nawaz from Beximco Pharma, BCIC Chairman Imdadul Haque, and an Industries Ministry official representing the government. 

Sanofi Bangladesh is part of global biopharmaceutical company Sanofi SA. Sanofi started operating in Bangladesh in 1958 as part of May & Baker, a British chemical company. Following a series of mergers, it became known as Sanofi-Aventis in 2004, before being renamed Sanofi Bangladesh Limited in 2013.

Sanofi Bangladesh's state-of-the-art manufacturing facility is near Beximco Pharma's manufacturing facility in Tongi, producing approximately 100 branded generic products, mainly for the local market. It has a strong presence in cardiology, diabetes, oncology, and dermatology. International parent company Sanofi SA also provides its global brands of vaccines, insulins and chemotherapy drugs, directly imported by Sanofi Bangladesh.

This acquisition is the biggest in the history of the pharmaceutical industry in Bangladesh.

Economy

Beximco Pharma / Sanofi / Beximco Pharmaceuticals Limited

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Bangladesh and US hold tariff talks on 11 July 2025. Photo: CA Press Wing
    Dhaka, Washington yet to agree on 20% of US tariff conditions: BGMEA
  • A file photo of BNP acting chairman Tarique Rahman speaking virtually at a party programme. Photo: Collected
    ‘Why is govt allowing this’: Tarique calls for crackdown on mob violence
  • Rakibul Alam Chowdhury, former vice-president of BGMEA. Photo: Courtesy
    35% US tariff: Bangladesh’s $10b garment trade teeters on edge

MOST VIEWED

  • Representational image
    In addition to 35% tariff, US demands 40% local value addition for 'Made in Bangladesh' goods
  • Screengrab blurred
    Killers bash in head of man with rock, stomp body with perverse pleasure
  • How tender rules and a lone bidder stall a $2.5b power plant
    How tender rules and a lone bidder stall a $2.5b power plant
  • Economist Abul Barkat; Photo: Courtesy
    Economist Abul Barkat arrested in graft case
  • Photo: UNB
    WHO's Saima Wazed Putul 'placed on indefinite leave' amid corruption allegations: Health Policy Watch
  • After India's visa restriction, China's Kunming is drawing Bangladeshi patients
    After India's visa restriction, China's Kunming is drawing Bangladeshi patients

Related News

  • Beximco Pharma contributes to Labour Welfare Foundation
  • Beximco Pharma signs MoU with North South University
  • Beximco Pharma's share price plummets 47% since July
  • Beximco Pharma unaware of reasons behind share price drop
  • How Salman F Rahman makes billions with free bank money

Features

The 2020 Harrier's Porsche Cayenne coupe-like rear roofline, integrated LED lighting with the Modellista special bodykit all around, and a swanky front grille scream OEM Plus for the sophisticated enthusiast looking for a bigger family car that isn’t boring. PHOTO: Ahbaar Mohammad

2020 Toyota Harrier Hybrid: The Japanese Macan

2h | Wheels
The showroom was launched through a lavish event held there, and in attendance were DHS Motors’ Managing Director Nafees Khundker, CEO Imran Zaman Khan, and GMs Arman Rashid and Farhan Samad. PHOTO: Akif Hamid

GAC inaugurate flagship showroom in Dhaka

3h | Wheels
After India's visa restriction, China's Kunming is drawing Bangladeshi patients

After India's visa restriction, China's Kunming is drawing Bangladeshi patients

1d | Panorama
Photo: Collected/BBC

What Hitler’s tariff policy misfire can teach the modern world

1d | The Big Picture

More Videos from TBS

Flashpoint Cumilla: where the July coup turned violent

Flashpoint Cumilla: where the July coup turned violent

13m | TBS Stories
US-Canada trade talks still uncertain

US-Canada trade talks still uncertain

2h | TBS World
Air India crash: What happened before the plane crashed?

Air India crash: What happened before the plane crashed?

3h | TBS World
Home Affairs Advisor calls on everyone to come forward and stop violence

Home Affairs Advisor calls on everyone to come forward and stop violence

5h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net